Sarah Bhagat's most recent trade in Inozyme Pharma Inc was a trade of 28,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inozyme Pharma Inc | Sarah Bhagat | Director | 18 Jun 2024 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | ||
| Inozyme Pharma Inc | Sarah Bhagat | Director | 13 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | ||
| Inozyme Pharma Inc | Sarah Bhagat | Director | 10 Jun 2022 | 9,367 | 9,367 | - | - | Stock Option (right to buy) | ||
| Inozyme Pharma Inc | Sarah Bhagat | Director | 23 Jun 2021 | 9,367 | 9,367 | - | - | Stock Option (right to buy) |